Malta - enska - Medicines Authority

mylan ire healthcare limited - clarithromycin - granules for oral suspension - clarithromycin 125 milligram(s)/5 millilitre - antibacterials for systemic use

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abbvie srl - clarithromycin - granules for oral suspension - 25 mg/ml

Malta - enska - Medicines Authority

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - coated tablet - clarithromycin 250 mg - antibacterials for systemic use

Írland - enska - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - clarithromycin - granules for oral suspension - 125 mg/5ml

Malta - enska - Medicines Authority

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - coated tablet - clarithromycin 500 mg - antibacterials for systemic use

Malta - enska - Medicines Authority

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - modified-release tablet - clarithromycin 500 mg - antibacterials for systemic use

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - clarithromycin 500mg;  ; clarithromycin 500mg - film coated tablet - 500 mg - active: clarithromycin 500mg   excipient: croscarmellose sodium hydrated silica hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc quinoline yellow sorbic acid sorbitan oleate stearic acid titanium dioxide vanillin active: clarithromycin 500mg excipient: colloidal silicon dioxide croscarmellose sodium ethanol   hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc purified water quinoline yellow sorbic acid sorbitan oleate stearic acid titanium dioxide vanillin - klacid tablets are indicated for treatment of infections caused by susceptible organisms. such infections include: · respiratory tract infections including bronchitis, pneumonia, tonsillitis, sinusitis and pharyngitis. · skin and soft tissue infections such as folliculitis, cellulitis and erysipelas. · disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localized infections due to mycobacterium chelonae, mycobacterium fortuitum, or mycobacterium kansasii. · prevention of disseminated mycobacterium avium complex infection in hiv-infected patients with cd4 lymphocyte counts less than or equal to 100/mm3. · clarithromycin in the presence of acid suppression is indicated for the treatment of duodenal ulcer and in reducing the rate of ulcer recurrence.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - clarithromycin 500mg;   - powder for injection - 500 mg - active: clarithromycin 500mg   excipient: lactobionic acid sodium hydroxide - klacid i.v. is indicated whenever parenteral therapy is required for treatment of sensitive microorganisms in the following conditions: · upper respiratory tract infections. · lower respiratory tract infections. · skin and soft tissue infections.

Jórdanía - enska - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 125 mg/5ml - 125 mg/5ml

Jórdanía - enska - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 125 mg/5ml - 125 mg/5ml